İlhami Er, M. Kırlı, O. Cetinayak, Barbaros Aydin, Nesrin Akturk, V. Karaçam, I. Oztop, A. Demi̇ral, R. Çetingoz
{"title":"Long-Term Survival With Salvage Surgery in Persistent Lung Cancer","authors":"İlhami Er, M. Kırlı, O. Cetinayak, Barbaros Aydin, Nesrin Akturk, V. Karaçam, I. Oztop, A. Demi̇ral, R. Çetingoz","doi":"10.30621/jbachs.2019.632","DOIUrl":null,"url":null,"abstract":"Objective: Our study presents a case with locally-advanced non-small cell lung cancer (NSCLC) having salvage pneumonectomy due to persistent disease. Case Description: A 46-year old man with stage IIIB (cT4N3M0) NSCLC received 39Gy (13x3Gy) thoracic radiotherapy after neoadjuvant chemotherapy. Partial response was obtained after radiotherapy. Chemotherapy was continued after radiotherapy. At 28th month of followup without treatment, isolated local progression was detected. The patient underwent right pneumonectomy and mediastinal lymph node dissection revealing ypT2aN0 adenocarcinoma. After adjuvant chemotherapy, he’s disease-free at 88 months after salvage surgery. Conclusion: In selected patients, salvage surgery seems to provide increased survival causing acceptable morbidity and mortality.","PeriodicalId":245385,"journal":{"name":"The Journal of Basic and Clinical Health Sciences","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Basic and Clinical Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30621/jbachs.2019.632","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Our study presents a case with locally-advanced non-small cell lung cancer (NSCLC) having salvage pneumonectomy due to persistent disease. Case Description: A 46-year old man with stage IIIB (cT4N3M0) NSCLC received 39Gy (13x3Gy) thoracic radiotherapy after neoadjuvant chemotherapy. Partial response was obtained after radiotherapy. Chemotherapy was continued after radiotherapy. At 28th month of followup without treatment, isolated local progression was detected. The patient underwent right pneumonectomy and mediastinal lymph node dissection revealing ypT2aN0 adenocarcinoma. After adjuvant chemotherapy, he’s disease-free at 88 months after salvage surgery. Conclusion: In selected patients, salvage surgery seems to provide increased survival causing acceptable morbidity and mortality.